Rochester, NY 7/14/2009 4:49:32 AM
After Market Results - CYTR - CytRx Corporation Files Report with FDA in Response to Clinical Trial - Sourced WhisperFromWallStreet.com
CytRx Corporation
After Market Results - CYTR - CytRx Corporation Files Report with FDA in Response to Clinical Trial - Sourced WhisperFromWallStreet.com
CytRx Corporation, CYTR
CytRx Corporation announced that it has filed a report with the U.S. Food and Drug Administrations (FDA) in response to the Agency`s partial clinical hold on the Company`s Phase 2b efficacy clinical trial with its molecular chaperone regulator drug candidate arimoclomol for the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig`s disease).
ABOUT
CytRx Corporation, a biopharmaceutical research and development company, engages in the development of human therapeutics. Its product pipeline includes Tamibarotene, a synthetic retinoid in Phase II clinical development to treat acute promyelocytic leukemia; INNO-2006, a pro-drug for doxorubicin in Phase II clinical development for the treatment of cancer; Bafetinib, a drug in Phase I clinical development to treat chronic myeloid leukemia; Arimoclomol, an orally-administered small-molecule product candidate in Phase IIb clinical development for the treatment of amyotrophic lateral sclerosis; and Iroxanadine, an orally-administered small-molecule product candidate in Phase I clinical development to treat diabetic ulcers.
Last Trade: 1.09
Day's Range: 1.05 - 1.24
52wk Range: 0.23 - 1.21
Volume: 3,188,253
WhisperfromWallStreet.com has a proven track record in picking winning stocks. While neither we nor anyone can offer a guarantee, we scan countless stocks on a daily basis to seek out those that have the greatest opportunity for gain. When we find these stocks, we immediately send an alert to our membership. Please feel free to track our results by joining our newsletter free. So far in 2009 we have sent over 40 alerts to our members with an average gain of over 80%.
Join our stock alert service free.
If you're an investor and interested in knowing which penny stocks are getting ready to run, sign up for our penny alerts at http://whisperfromwallstreet.com/
During 2009 we have sent out over 40 stock alerts resulting in an over 80% price gain. Sign up now FREE to track our results.
---
Disclaimer: Full disclaimer at http://whisperfromwallstreet.com/disclaimer.php
IMPORTANT NOTE: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. This press release should not be construed as a solicitation to buy or sell any particular stock or security. Neither WhisperfromWallstreet, nor any of its affiliates are registered investment advisors or broker dealers.
